Experimental Factor Ontology (EFO) Information | |
Identifier | EFO_0007012 |
Description | quantification of some aspect of NSAID use | Trait category |
Other measurement
|
Synonym | non-steroid anti-inflammatory drug use measurement |
Child trait(s) | aspirin use measurement |
Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
---|---|---|---|---|---|---|
PGS001112 (GBE_BIN_FC1006154) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Aspirin | aspirin use measurement | 499 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001112/ScoringFiles/PGS001112.txt.gz |
PGS001113 (GBE_BIN_FC7006154) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Aspirin use self-reported | aspirin use measurement | 790 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001113/ScoringFiles/PGS001113.txt.gz |
PGS001114 (GBE_BIN_FC8006154) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Ibuprofen use, self-reported | NSAID use measurement, self-reported trait |
419 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001114/ScoringFiles/PGS001114.txt.gz |
PGS001115 (GBE_BIN_FC9006154) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Paracetamol use self-reported | NSAID use measurement, self-reported trait |
4,673 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001115/ScoringFiles/PGS001115.txt.gz |
PGS001116 (GBE_BIN_FC2006154) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Ibuprofen use | NSAID use measurement | 174 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001116/ScoringFiles/PGS001116.txt.gz |
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|---|
PPM008298 | PGS001112 (GBE_BIN_FC1006154) |
PSS003785| African Ancestry| 6,221 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Aspirin | — | AUROC: 0.69049 [0.67139, 0.70958] | R²: 0.10001 Incremental AUROC (full-covars): -0.00083 PGS R2 (no covariates): 2e-05 PGS AUROC (no covariates): 0.49929 [0.47866, 0.51992] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008299 | PGS001112 (GBE_BIN_FC1006154) |
PSS003786| East Asian Ancestry| 1,584 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Aspirin | — | AUROC: 0.70571 [0.6571, 0.75432] | R²: 0.08987 Incremental AUROC (full-covars): 0.0038 PGS R2 (no covariates): 0.00669 PGS AUROC (no covariates): 0.56392 [0.50988, 0.61796] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008300 | PGS001112 (GBE_BIN_FC1006154) |
PSS003787| European Ancestry| 24,612 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Aspirin | — | AUROC: 0.68372 [0.67417, 0.69326] | R²: 0.09126 Incremental AUROC (full-covars): 0.00057 PGS R2 (no covariates): 0.00095 PGS AUROC (no covariates): 0.51838 [0.50799, 0.52876] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008301 | PGS001112 (GBE_BIN_FC1006154) |
PSS003788| South Asian Ancestry| 7,364 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Aspirin | — | AUROC: 0.73243 [0.71849, 0.74637] | R²: 0.16473 Incremental AUROC (full-covars): 0.00284 PGS R2 (no covariates): 0.00525 PGS AUROC (no covariates): 0.5396 [0.52315, 0.55606] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008302 | PGS001112 (GBE_BIN_FC1006154) |
PSS003789| European Ancestry| 66,854 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Aspirin | — | AUROC: 0.70264 [0.69719, 0.70809] | R²: 0.11105 Incremental AUROC (full-covars): 0.00128 PGS R2 (no covariates): 0.00131 PGS AUROC (no covariates): 0.52069 [0.5145, 0.52688] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008303 | PGS001113 (GBE_BIN_FC7006154) |
PSS004009| African Ancestry| 3,878 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Aspirin use self-reported | — | AUROC: 0.70614 [0.68626, 0.72603] | R²: 0.14457 Incremental AUROC (full-covars): -0.00059 PGS R2 (no covariates): 1e-05 PGS AUROC (no covariates): 0.50282 [0.48118, 0.52447] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008304 | PGS001113 (GBE_BIN_FC7006154) |
PSS004010| East Asian Ancestry| 1,243 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Aspirin use self-reported | — | AUROC: 0.72184 [0.67304, 0.77064] | R²: 0.11704 Incremental AUROC (full-covars): 0.0056 PGS R2 (no covariates): 0.00908 PGS AUROC (no covariates): 0.56298 [0.50935, 0.6166] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008305 | PGS001113 (GBE_BIN_FC7006154) |
PSS004011| European Ancestry| 17,534 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Aspirin use self-reported | — | AUROC: 0.67932 [0.66939, 0.68925] | R²: 0.09827 Incremental AUROC (full-covars): 0.00128 PGS R2 (no covariates): 0.00172 PGS AUROC (no covariates): 0.52387 [0.51314, 0.53459] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008306 | PGS001113 (GBE_BIN_FC7006154) |
PSS004012| South Asian Ancestry| 5,363 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Aspirin use self-reported | — | AUROC: 0.73075 [0.71607, 0.74542] | R²: 0.18147 Incremental AUROC (full-covars): 0.00255 PGS R2 (no covariates): 0.00504 PGS AUROC (no covariates): 0.53563 [0.51845, 0.55281] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008307 | PGS001113 (GBE_BIN_FC7006154) |
PSS004013| European Ancestry| 47,360 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Aspirin use self-reported | — | AUROC: 0.69034 [0.68459, 0.69609] | R²: 0.11184 Incremental AUROC (full-covars): 0.00181 PGS R2 (no covariates): 0.00219 PGS AUROC (no covariates): 0.52532 [0.51891, 0.53174] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008308 | PGS001114 (GBE_BIN_FC8006154) |
PSS004019| African Ancestry| 4,198 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Ibuprofen use self-reported | — | AUROC: 0.58623 [0.56747, 0.60499] | R²: 0.02659 Incremental AUROC (full-covars): 0.00105 PGS R2 (no covariates): 0.00105 PGS AUROC (no covariates): 0.51676 [0.49751, 0.53601] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008309 | PGS001114 (GBE_BIN_FC8006154) |
PSS004020| East Asian Ancestry| 1,283 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Ibuprofen use self-reported | — | AUROC: 0.63391 [0.58944, 0.67838] | R²: 0.07333 Incremental AUROC (full-covars): 0.00219 PGS R2 (no covariates): 0.00605 PGS AUROC (no covariates): 0.55222 [0.50424, 0.60019] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008310 | PGS001114 (GBE_BIN_FC8006154) |
PSS004021| European Ancestry| 18,055 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Ibuprofen use self-reported | — | AUROC: 0.59904 [0.58905, 0.60903] | R²: 0.03286 Incremental AUROC (full-covars): 0.00267 PGS R2 (no covariates): 0.00221 PGS AUROC (no covariates): 0.52523 [0.51521, 0.53524] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008311 | PGS001114 (GBE_BIN_FC8006154) |
PSS004022| South Asian Ancestry| 4,705 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Ibuprofen use self-reported | — | AUROC: 0.61281 [0.59188, 0.63374] | R²: 0.036 Incremental AUROC (full-covars): -0.00199 PGS R2 (no covariates): 3e-05 PGS AUROC (no covariates): 0.49833 [0.47621, 0.52045] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008312 | PGS001114 (GBE_BIN_FC8006154) |
PSS004023| European Ancestry| 47,828 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Ibuprofen use self-reported | — | AUROC: 0.59831 [0.59215, 0.60447] | R²: 0.03148 Incremental AUROC (full-covars): 0.00304 PGS R2 (no covariates): 0.00188 PGS AUROC (no covariates): 0.52406 [0.51781, 0.5303] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008313 | PGS001115 (GBE_BIN_FC9006154) |
PSS004024| African Ancestry| 5,085 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Paracetamol use self-reported | — | AUROC: 0.61918 [0.60368, 0.63468] | R²: 0.05618 Incremental AUROC (full-covars): -0.00248 PGS R2 (no covariates): 0.00088 PGS AUROC (no covariates): 0.514 [0.49793, 0.53008] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008314 | PGS001115 (GBE_BIN_FC9006154) |
PSS004025| East Asian Ancestry| 1,387 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Paracetamol use self-reported | — | AUROC: 0.66023 [0.62475, 0.6957] | R²: 0.10401 Incremental AUROC (full-covars): 0.00543 PGS R2 (no covariates): 0.00338 PGS AUROC (no covariates): 0.53113 [0.49267, 0.56958] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008315 | PGS001115 (GBE_BIN_FC9006154) |
PSS004026| European Ancestry| 19,451 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Paracetamol use self-reported | — | AUROC: 0.58754 [0.57874, 0.59635] | R²: 0.02785 Incremental AUROC (full-covars): 0.01048 PGS R2 (no covariates): 0.0066 PGS AUROC (no covariates): 0.54192 [0.53304, 0.5508] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008316 | PGS001115 (GBE_BIN_FC9006154) |
PSS004027| South Asian Ancestry| 5,818 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Paracetamol use self-reported | — | AUROC: 0.62877 [0.61375, 0.6438] | R²: 0.06084 Incremental AUROC (full-covars): 0.00451 PGS R2 (no covariates): 0.0045 PGS AUROC (no covariates): 0.53799 [0.52235, 0.55363] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008317 | PGS001115 (GBE_BIN_FC9006154) |
PSS004028| European Ancestry| 52,582 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Paracetamol use self-reported | — | AUROC: 0.60087 [0.59559, 0.60615] | R²: 0.03601 Incremental AUROC (full-covars): 0.01595 PGS R2 (no covariates): 0.01072 PGS AUROC (no covariates): 0.55514 [0.54977, 0.56051] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008318 | PGS001116 (GBE_BIN_FC2006154) |
PSS003859| African Ancestry| 6,221 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Ibuprofen (e.g. Nurofen) | — | AUROC: 0.59205 [0.57467, 0.60944] | R²: 0.02759 Incremental AUROC (full-covars): -0.00015 PGS R2 (no covariates): 0.00046 PGS AUROC (no covariates): 0.50964 [0.4914, 0.52789] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008319 | PGS001116 (GBE_BIN_FC2006154) |
PSS003860| East Asian Ancestry| 1,584 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Ibuprofen (e.g. Nurofen) | — | AUROC: 0.61277 [0.5683, 0.65725] | R²: 0.04562 Incremental AUROC (full-covars): 0.00152 PGS R2 (no covariates): 0.00555 PGS AUROC (no covariates): 0.54922 [0.50243, 0.59601] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008320 | PGS001116 (GBE_BIN_FC2006154) |
PSS003861| European Ancestry| 24,612 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Ibuprofen (e.g. Nurofen) | — | AUROC: 0.61988 [0.61042, 0.62934] | R²: 0.04208 Incremental AUROC (full-covars): 0.00089 PGS R2 (no covariates): 0.001 PGS AUROC (no covariates): 0.51881 [0.50908, 0.52853] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008321 | PGS001116 (GBE_BIN_FC2006154) |
PSS003862| South Asian Ancestry| 7,364 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Ibuprofen (e.g. Nurofen) | — | AUROC: 0.62217 [0.6023, 0.64205] | R²: 0.03601 Incremental AUROC (full-covars): -0.00195 PGS R2 (no covariates): 0.00051 PGS AUROC (no covariates): 0.48821 [0.46651, 0.50992] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM008322 | PGS001116 (GBE_BIN_FC2006154) |
PSS003863| European Ancestry| 66,854 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Ibuprofen (e.g. Nurofen) | — | AUROC: 0.61851 [0.6127, 0.62433] | R²: 0.03928 Incremental AUROC (full-covars): 0.00101 PGS R2 (no covariates): 0.00076 PGS AUROC (no covariates): 0.51542 [0.50941, 0.52143] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS004028 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
PSS003785 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS003786 | — | — | [
|
— | East Asian | — | UKB | — |
PSS003787 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS003788 | — | — | [
|
— | South Asian | — | UKB | — |
PSS003789 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
PSS003859 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS003860 | — | — | [
|
— | East Asian | — | UKB | — |
PSS003861 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS003862 | — | — | [
|
— | South Asian | — | UKB | — |
PSS003863 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
PSS004009 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004010 | — | — | [
|
— | East Asian | — | UKB | — |
PSS004011 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS004012 | — | — | [
|
— | South Asian | — | UKB | — |
PSS004013 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
PSS004019 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004020 | — | — | [
|
— | East Asian | — | UKB | — |
PSS004021 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS004022 | — | — | [
|
— | South Asian | — | UKB | — |
PSS004023 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |
PSS004024 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004025 | — | — | [
|
— | East Asian | — | UKB | — |
PSS004026 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS004027 | — | — | [
|
— | South Asian | — | UKB | — |